Filing Details

Accession Number:
0001209191-20-007060
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-05 20:21:37
Reporting Period:
2020-02-04
Accepted Time:
2020-02-05 20:21:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645666 Kezar Life Sciences Inc. KZR Pharmaceutical Preparations (2834) 473366145
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744263 Franklin John Fowler C/O Kezar Life Sciences, Inc.
4000 Shoreline Court, Suite 300
South San Francisco CA 94080
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-04 38,461 $2.60 38,461 No 4 P Indirect By Montebello Holdings LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Montebello Holdings LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,750 Indirect By Trust
Common Stock 343,204 Direct
Footnotes
  1. Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.
  2. The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.